Ellasie Formulation Standards

How Ellasie Chooses Supplement Ingredients

Ellasie does not use one identical development model for every supplement. Some formulas may be developed or directed with Ellasie input, some are manufacturer-developed formulas selected after assessment, and some products may be sourced as finished formulations.

In every case, the responsible standard is to explain what Ellasie actually assessed: the current formula, daily serving, ingredient disclosure, supplier documentation, regulatory fit, evidence boundaries and suitability for the intended product format.

Last updated: 24 juli 2026 Three formulation routes Product-specific case studies

Our standard in one sentence

Ellasie should describe a formula according to its real development route and current documentation — without claiming that every ingredient was independently chosen, clinically dosed, strain-verified or tested through shelf life unless product-specific evidence supports that statement.

Three ways an Ellasie formula may enter the range

The route affects what Ellasie can honestly say about authorship, ingredient selection and dosage decisions.

1

Ellasie-developed or directed formulas

Ellasie may influence one or more parts of development, such as ingredient selection, dosage, format, flavour, supplier specification, serving size or product positioning.

The page should still distinguish decisions made by Ellasie from technical work completed by the manufacturer, formulator or ingredient supplier.

2

Selected manufacturer formulas

A manufacturer may already have developed the core formula. Ellasie then assesses the label, ingredients, quantities, format, supplier documents, market fit and claims before deciding whether to range it.

Selecting the formula responsibly does not mean Ellasie originated every ingredient or dose.

3

Sourced finished products

Some finished products may be sourced for the Ellasie range without Ellasie controlling the original formulation process.

In that situation, Ellasie’s role is to assess suitability, documentation, labelling, regulatory fit and customer relevance rather than claiming original formulation ownership.

A product can change route over time. A selected formula may later be reformulated or further directed by Ellasie. The current product specification and evidence record should remain the source of truth.

The formulation assessment framework

These questions are relevant whether Ellasie originated the formula, selected it from a manufacturer or sourced it as a finished product.

1

What is the development route?

Record who developed the formula and which decisions Ellasie, the manufacturer, formulator or supplier actually controlled.

2

What exactly is disclosed?

Check ingredient names, forms, strain codes where relevant, individual quantities, blend totals, excipients, allergens and daily serving.

3

What is the dosage context?

Compare the daily amount with nutritional requirements, authorised-claim conditions, safety information and research relevant to the exact ingredient form.

4

What evidence is relevant?

Separate evidence for an ingredient, a branded ingredient, a strain, a combination and the complete finished product.

5

What claims are legally usable?

Check whether proposed nutrition or health claims are authorised or otherwise permitted and whether the product meets their conditions of use.

6

What safety factors apply?

Review allergens, upper levels, medicine interactions, pregnancy or breastfeeding restrictions, age limits and warnings relevant to the formula.

7

What documentation exists?

Identify product specifications, supplier declarations, facility certificates, stability support and laboratory reports without treating them as interchangeable.

8

Can the formula be explained honestly?

Use plain language that distinguishes known facts, reasonable rationale, uncertain evidence and commercial positioning.

Ingredient evidence is not the same as a product claim

This distinction is essential for trustworthy supplement communication.

Evidence level What it may support What it does not automatically support
General nutrient research Background on a nutrient’s biological role and established requirements. A claim that an Ellasie product treats a symptom or produces the same outcome as a study.
Authorised nutrient claim The permitted claim when the product meets the exact conditions of use. Broader disease, treatment or symptom claims beyond the authorised wording.
Research on a botanical Scientific context for a particular extract, dose and population. That any powder or extract of the same plant is equivalent, or that the finished blend has been clinically tested.
Research on a probiotic strain Evidence relevant to the exact strain, dose, formulation, route and outcome studied. That species-only disclosure, another strain or a multi-strain blend produces the same result.
Finished-product study Evidence for the tested product under the study conditions. Guaranteed results for every person or permission to make unauthorised health or disease claims.
Commercial claims in Great Britain are separately regulated. Only authorised health claims in the Great Britain register may be used as authorised claims, subject to their conditions. Food supplements cannot be presented as treating, preventing or curing disease.

How we assess probiotic ingredients

Probiotic assessment requires more than reading a genus and species name from the label.

Species disclosure and strain disclosure

A species name such as Lactobacillus rhamnosus is not the same as a complete strain designation. Evidence from one strain should not be transferred automatically to an unnamed or different strain.

Where only species are shown, Ellasie should describe them as listed species rather than implying that a specific clinically studied strain is present.

CFU and shelf-life wording

CFU at manufacture, CFU at release and CFU through the end of shelf life are different statements. An end-of-shelf-life claim requires suitable stability or supplier documentation for the formula and storage conditions concerned.

The public reports currently shown on Testing and Quality do not verify probiotic CFU or strain identity.

Prebiotic ingredients

A prebiotic ingredient can have a legitimate formulation rationale, but adding fibre does not automatically prove improved probiotic colonisation or a synergistic finished-product effect.

Product wording should identify the included substrate and avoid promising an effect that has not been demonstrated for that specific combination.

Format and practicality

Capsules, gummies and powders create different stability, serving, storage and adherence considerations. Format can support practical use, but it does not make a formula clinically effective on its own.

The broader principles are explained in Probiotics 101.

Three formulation case studies

These examples show how Ellasie can explain current formulas without pretending that every ingredient decision or health outcome has the same level of evidence.

Vaginale Probiotica Capsules voor Vrouwen – pH-balans £21.99
Beoordeling van de huidige formule

Vaginale Probiotica Capsules voor Vrouwen – pH-balans

A capsule formula with a listed Lactobacillus culture blend and XOS prebiotic fibre. The case study separates what the current label states from what the public laboratory reports verify.

Current disclosure Two capsules per daily serving, four listed Lactobacillus species, 5 × 109 CFU per daily dose stated at end of shelf life, and 400 mg XOS.
Formulation rationale A targeted capsule format allows a defined daily serving and combines live cultures with a separately quantified prebiotic fibre.
Transparency strength The daily CFU total, listed species, serving and XOS quantity are visible to the customer.
Disclosure limitation The public label does not show strain codes or the individual quantity contributed by each listed species within the blend.
Evidence boundary: the public Eurofins reports cover selected microbiological analytes and four elements. They do not verify strain identity, CFU potency, XOS quantity or viability through expiry. The end-of-shelf-life statement therefore must rely on separate current documentation.
View product Vaginal Microbiome guide Testing evidence
Feminine Balance Gummies voor Vrouwen – pH-balans & Ananas £21.99
Beoordeling van de huidige formule

Feminine Balance Gummies voor Vrouwen – pH-balans & Ananas

A chewable formula currently presented with a named Bacillus coagulans strain, vitamin C and a two-gummy daily serving.

Current disclosure Two gummies per day, 2 billion CFU Bacillus coagulans SNZ 1969™ per serving, vitamin C, a 30-day supply, and product-specific vegan and sugar-free statements.
Format rationale The gummy format offers a chewable option for customers who do not want capsules, while the spore-forming culture suits a shelf-stable format.
Claim distinction Vitamin C may support authorised nutrient claims when the product meets their conditions. The probiotic ingredient should not be treated as an authorised vaginal-health claim.
Documentation need The stated end-of-shelf-life CFU, strain identity, vegan status and sugar-free status should remain linked to current product and supplier documentation.
Evidence boundary: a named and studied strain does not prove that this finished gummy treats infection, changes vaginal pH or produces every outcome studied in another formulation. Format convenience and clinical effect are separate questions.
View product Probiotics 101 Testing standards
Ondersteuning bij de menopauze | Hormonaal welzijn en botgezondheid £21.99
Beoordeling van de huidige formule

Ondersteuning bij de menopauze | Hormonaal welzijn en botgezondheid

A multi-ingredient capsule formula combining vitamins B6, D3 and K2 with ashwagandha, chasteberry and black cohosh.

Current disclosure A two-capsule daily routine with vitamins B6, D3 and K2 plus a botanical blend containing ashwagandha root extract, chasteberry fruit extract and black cohosh root extract.
Authorised rationale The clearest commercial claim foundation comes from authorised nutrient claims for B6, vitamin D and vitamin K, subject to conditions of use.
Botanical context The botanicals may have research or traditional-use context, but their presence does not authorise broad claims that the complete product treats menopause symptoms.
Transparency limitation Where botanicals are grouped in a blend, the page should not imply that each botanical is present at a specific clinically studied amount unless individual quantities substantiate it.
Evidence boundary: a multi-ingredient menopause supplement is not a replacement for HRT, vaginal oestrogen, CBT or medical assessment. Nutrient claims and botanical evidence should remain clearly separated.
View product Menopause guide Testing standards

What Ellasie prefers — and what requires qualification

These are decision principles, not universal claims about every historic or current SKU.

Prefer

Clear daily quantities

Individual active amounts, serving size and blend totals should be visible wherever the available specification allows them to be disclosed.

Qualify

Blends and grouped ingredients

Where individual amounts are not disclosed, Ellasie should explain that limitation rather than describing the formula as fully dose-transparent.

Prefer

Exact forms and strains

Branded extracts, nutrient forms and probiotic strain codes should be named when current documentation confirms them.

Qualify

Research extrapolation

Evidence for one extract, strain or dose should not be applied to a generic ingredient, another form or an untested finished product.

Prefer

Necessary excipients

Excipients should serve a formulation, stability, manufacturing, flavour or format purpose and remain declared in accordance with labelling requirements.

Qualify

“Clean”, “natural” and “premium” language

These broad terms do not replace precise ingredient, dosage, testing or regulatory information.

Prefer

Product-specific dietary markers

Vegan, halal, non-GMO and sugar-free statements should be attached to the formula and documentation that support them.

Avoid

Claims based on label decoration

An ingredient should not be added or promoted merely because it creates a fashionable claim, a longer label or an appearance of clinical strength.

Formula, supplier and label changes

Ingredient standards must follow the product that is actually being sold, not an older specification.

What should trigger review

  • A different manufacturer, ingredient supplier or branded ingredient
  • A changed active amount, serving size, strain or nutrient form
  • A new excipient, allergen or dietary marker
  • A changed stability, shelf-life or storage statement
  • A new health, nutrition or comparative claim
  • A material difference between packaging and the live product page

What should be updated

  • The product specification and approved label
  • The PDP ingredient table and directions
  • Testing, certification and supplier-document references
  • Relevant educational or comparison copy
  • Feed attributes used in advertising or shopping channels
  • Review badges when the revised claims require reassessment
Product testing and documents are addressed on Testing and Quality. Content re-review is handled according to the Medical Review Policy.

UK regulatory reference points

These official sources help frame ingredient, labelling and claims decisions for products sold in Great Britain.

Food Standards Agency: Food supplements Business guidance on supplement responsibilities. Great Britain nutrition and health claims register Authorised and non-authorised nutrition and health claims. Nutrition and health claims compliance guidance How commercial claims are assessed and used. Food labelling, claims and supplement labelling Official overview of claims and disease-treatment restrictions.

Frequently asked questions

Does Ellasie formulate every product from scratch?
No. Ellasie uses different routes. Some formulas may be developed or directed with Ellasie input, some are manufacturer-developed formulas selected after assessment, and some may be sourced as finished products.
What does Ellasie assess in a manufacturer-developed formula?
The assessment can include ingredient and dosage disclosure, serving, label clarity, regulatory fit, supplier documentation, dietary markers, format, intended customer, evidence boundaries and the claims proposed for the product.
Does every ingredient have a clinically proven dose?
That should not be assumed. Evidence may relate to a different form, branded extract, strain, dose or combination. Where ingredients are grouped in a blend or individual amounts are not disclosed, Ellasie should not claim that every component matches a clinically studied dose.
Does Ellasie avoid all proprietary or grouped blends?
Not every current formula provides individual quantities for every component. The responsible approach is to disclose available amounts and explain limitations rather than claiming that the entire range avoids grouped blends.
Why do probiotic strain codes matter?
Research can be strain-specific. Evidence for one strain should not automatically be applied to another strain or to a product that lists only the species name. Species disclosure and full strain disclosure are different levels of information.
Does the Testing and Quality page verify ingredient doses?
Only where a published or internal document actually covers that quantity. The current public Intimate Balance reports cover selected microbiological analytes and four elements; they do not verify probiotic CFU, strain identity or complete label potency.
Are ingredient studies enough to make a health claim?
No. Commercial nutrition and health claims in Great Britain must comply with the applicable claims rules and conditions. Research interest in an ingredient does not automatically authorise a claim for a product.
Are all Ellasie products vegan, halal or non-GMO?
These statements should be confirmed product by product using the current formulation and documentation. A range-wide statement should not be inferred from one product or supplier declaration.
What happens when an ingredient supplier changes?
The specification, label, supplier documents, dietary markers, claims and relevant content should be reviewed. Existing statements should not be carried forward automatically when the underlying ingredient or evidence changes.
Can I ask why a specific ingredient is included?
Yes. Use the Ellasie contact page and include the product and ingredient. Ellasie can explain the available formulation rationale and documentation while separating general information from personal medical advice.

Questions about a formula or ingredient?

Use the Ellasie contact page and include the product name, ingredient and exact question. This helps the team check the current specification rather than relying on a general answer.

For medicine interactions, pregnancy, breastfeeding, diagnosed conditions or individual suitability, contact a qualified healthcare professional.